Episode 31: Polaris Partners' Amy Schulman

Episode 31

0:00-1:02:40

She describes her career beginnings as a lawyer, which led to general counsel and business unit head roles at Pfizer, and then joining the VC world at Polaris Partners (at Bob Langer's urging). She discusses the firm's investment philosophy, the nuances behind how companies choose lead assets, and the cycles biotech has been through over the last ten years. Plus, other roles she currently serves, including being the chair of Alnylam.

Publisher

BioVenture VoiCes with Chris Garabedian

Link

podcasters.spotify.com/pod/show/biotechtv7/episodes/Episode-31-Polaris-Partners-Amy-Schulman-e3cu1ih

Published

December 29, 2025

Duration

1h 3m

Format

Podcast

Category

Issues · Science

Source

RSS feed

Host

BiotechTV

BV

BioVenture VoiCes with Chris Garabedian

@bioventurevoiceswithchrisgar

#polarispartnersamy #lifesciences

The Nile